Showing results (2191-2200 of 2,450) with videos related to

Sort By:
Pageof 245
Optics Express|January 26, 2012
1.12 Tb/s superchannel coherent PM-QPSK InP transmitter photonic integrated circuit (PIC)P Evans, M Fisher, R Malendevich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2024
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient RecordsVirginia H Sun, Julius C Heemelaar, Ibrahim Hadzic, et al.
Blood|December 25, 2015
Targetable genetic features of primary testicular and primary central nervous system lymphomasBjoern Chapuy, Margaretha G M Roemer, Chip Stewart, et al.
Optics Express|October 19, 2017
Extended C-band tunable multi-channel InP-based coherent receiver PICsA Hosseini, M Lu, R Going, et al.
Physical Review Letters|April 30, 2021
New ^{59}Fe Stellar Decay Rate with Implications for the ^{60}Fe Radioactivity in Massive StarsB Gao, S Giraud, K A Li, et al.
Journal of Medicinal Chemistry|April 26, 2016
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 KinasePamela A Haile, Bartholomew J Votta, Robert W Marquis, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 2, 2018
[Willingness of potential service suppliers to provide cancer screening in urban China]A Y Mao, J F Shi, W Q Qiu, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 3, 2018
[Potential demand on cancer screening service in urban populations in China: a cross-sectional survey]H K Lei, P Dong, Q Zhou, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 2, 2018
[Preference on screening frequency and willingness-to-pay for multiple-cancer packaging screening programs in urban populations in China]J Zhu, H Y Huang, A Y Mao, et al.
Journal of Medicinal Chemistry|July 3, 2019
Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory DiseasesPamela A Haile, Linda N Casillas, Bartholomew J Votta, et al.
Pageof 245